Actylis Executive and Leadership Team

August, 2026

Leadership Overview

Actylis has 7 executives leading key functions including strategy, financial oversight, global nutrition, life sciences, and regional operations.

Driven by a commitment to supply chain excellence, Actylis delivers critical raw materials and performance ingredients to the Life Sciences, Specialty Chemicals, and Agriscience sectors through a robust hybrid manufacturing and sourcing model.

Leadership Roles at Actylis

  • Chief Executive Officer - Scott Thomson
  • Chief Financial Officer - Douglas Roth
  • Senior Vice President & Chief Financial Officer - Trae Etre
  • Director and Chief Financial Officer APAC - Arpit Butala
  • President, Global Nutrition and OTC - Mark Bostel
  • President Global Life Sciences - Damien O'Rourke
  • President (North America) - Keith Wilkinson
  • Scott Thomson - Chief Executive Officer

    Scott Thomson, the Chief Executive Officer at Actylis, directs the overarching corporate strategy and global expansion initiatives. Thomson architects the long-term vision for the organization, ensuring the hybrid manufacturing and sourcing model meets the complex demands of the Life Sciences and Specialty Chemicals industries. By aligning internal GMP and non-GMP facility capabilities with external sourcing hubs, the Chief Executive Officer optimizes supply chain reliability for customers worldwide. This leadership role involves constant collaboration with the Board to drive sustainable growth and maintain industry-leading regulatory compliance standards. Scott Thomson monitors market trends across the Agriscience sector to identify new opportunities for ingredient innovation. Through rigorous operational oversight, the Chief Executive Officer secures the company's position as a premier provider of critical raw materials. Ultimately, Thomson fosters a culture of quality and efficiency that supports the unique manufacturing requirements of a diverse global client base.

    Douglas Roth - Chief Financial Officer

    Douglas Roth, the Chief Financial Officer at Actylis, manages the financial health and fiscal strategy of the organization. Roth oversees capital allocation, budgeting, and financial reporting to ensure the company maintains the resources necessary for scaling global manufacturing operations. By analyzing the cost-efficiency of the hybrid sourcing model, the Chief Financial Officer provides actionable insights that support strategic decision-making across the Life Sciences and Specialty Chemicals divisions. This role involves maintaining strict adherence to financial regulations while optimizing the balance sheet for long-term stability. Douglas Roth coordinates with executive leadership to evaluate potential investments in new facilities and technology. Through precise financial planning, the Chief Financial Officer mitigates risks associated with global supply chain volatility. Ultimately, Roth drives the fiscal discipline required to sustain the company's competitive advantage in the demanding raw materials market, ensuring consistent value delivery for all stakeholders.

    Trae Etre - Senior Vice President & Chief Financial Officer

    Trae Etre, the Senior Vice President & Chief Financial Officer at Actylis, directs the financial operations and strategic planning for the enterprise. Etre architects complex financial frameworks that support the expansion of the company's global ingredient portfolio. By focusing on the integration of financial data with operational performance, the Senior Vice President & Chief Financial Officer ensures that the organization maintains high standards of quality documentation and regulatory compliance. This leadership role involves managing the financial aspects of the sourcing hub network to maximize profitability and operational flexibility. Trae Etre collaborates with other C-suite leaders to refine the business model for the Life Sciences and Agriscience industries. Through meticulous oversight of financial systems, the Senior Vice President & Chief Financial Officer supports the company's mission to provide reliable solutions for unique manufacturing requirements. Ultimately, Etre secures the financial foundation necessary for continuous innovation and market growth.

    Arpit Butala - Director and Chief Financial Officer APAC

    Arpit Butala, the Director and Chief Financial Officer APAC at Actylis, manages the financial strategy and operational performance within the Asia-Pacific region. Butala directs regional fiscal planning to ensure alignment with the broader global objectives of the company. By overseeing the financial health of regional sourcing hubs, the Director and Chief Financial Officer APAC optimizes the supply chain for customers requiring specialized ingredients in the Life Sciences and Specialty Chemicals sectors. This role involves navigating complex regional regulatory environments to maintain the company's reputation for quality and compliance. Arpit Butala works closely with global leadership to integrate APAC operations into the hybrid manufacturing model. Through strategic financial management, the Director and Chief Financial Officer APAC drives regional growth and operational efficiency. Ultimately, Butala ensures that the company's presence in the Asia-Pacific market remains robust, reliable, and capable of meeting the evolving needs of the global manufacturing landscape.

    Mark Bostel - President, Global Nutrition and OTC

    Mark Bostel, the President, Global Nutrition and OTC at Actylis, directs the strategic development and commercial success of the nutrition and over-the-counter ingredient portfolios. Bostel architects initiatives to expand the reach of these specialized products within the Life Sciences industry. By leveraging the company's hybrid manufacturing and sourcing model, the President, Global Nutrition and OTC ensures that customers receive high-quality, compliant ingredients tailored to specific manufacturing needs. This leadership role involves overseeing the product lifecycle from sourcing to final delivery, ensuring that all materials meet rigorous industry standards. Mark Bostel collaborates with global teams to identify emerging trends in the nutrition market and adapt the product strategy accordingly. Through focused operational management, the President, Global Nutrition and OTC drives revenue growth and strengthens the company's market position. Ultimately, Bostel delivers the flexibility and reliability required to support the complex manufacturing requirements of global nutrition and OTC clients.
    Mark Bostel

    Damien O'Rourke - President Global Life Sciences

    Damien O'Rourke, the President Global Life Sciences at Actylis, directs the strategic operations and market expansion for the Life Sciences division. O'Rourke architects solutions that provide critical raw materials to pharmaceutical and biotechnology customers worldwide. By managing the integration of GMP and non-GMP facilities, the President Global Life Sciences ensures that the company maintains the highest standards of quality documentation and regulatory compliance. This role involves coordinating with global sourcing hubs to secure difficult-to-find ingredients for complex manufacturing processes. Damien O'Rourke works with the executive team to align the division's output with the evolving needs of the global life sciences market. Through proactive leadership, the President Global Life Sciences drives operational excellence and fosters long-term partnerships with key industry players. Ultimately, O'Rourke ensures that the company remains a trusted partner for customers requiring reliable, high-quality ingredients for their most critical manufacturing projects.
    Damien O'Rourke

    Keith Wilkinson - President (North America)

    Keith Wilkinson, the President (North America) at Actylis, directs the regional operations and commercial strategy across the North American market. Wilkinson architects initiatives to enhance the company's service delivery for the Life Sciences, Specialty Chemicals, and Agriscience industries. By overseeing the regional supply chain and manufacturing capabilities, the President (North America) ensures that customers receive flexible and reliable solutions for their unique manufacturing requirements. This leadership role involves managing regional teams to maintain high standards of quality and regulatory compliance. Keith Wilkinson collaborates with global leadership to integrate North American operations into the broader corporate strategy. Through effective market engagement, the President (North America) drives regional growth and strengthens the company's competitive position. Ultimately, Wilkinson ensures that the organization provides the necessary support and expertise to meet the diverse needs of the North American manufacturing sector, maintaining the company's reputation for excellence and reliability.
    Keith Wilkinson

    Frequently Asked Questions Regarding Actylis Top Executives and Leadership Team

    Who leads Actylis?
    Actylis is led by Scott Thomson (Chief Executive Officer), along with executives such as Douglas Roth (Chief Financial Officer) and Trae Etre (Senior Vice President & Chief Financial Officer).
    Who is part of Actylis’s executive team?
    The executive team of Actylis includes leaders such as Scott Thomson (Chief Executive Officer), Douglas Roth (Chief Financial Officer), Trae Etre (Senior Vice President & Chief Financial Officer) and other senior executives.
    How many executives does Actylis have?
    Actylis has 7 executives leading key business areas.
    What roles are included in Actylis’s leadership team?
    The leadership team of Actylis includes roles such as Chief Executive Officer, Chief Financial Officer, Senior Vice President & Chief Financial Officer, Director and Chief Financial Officer APAC, President, Global Nutrition and OTC.